Elsevier Inc.

SHERPA: Unknown

People

  1. Park
    Park
  2. Perales
    Perales
  3. Palomba
    Palomba
  4. Giralt
    Giralt
  5. Shah
    Shah
  6. Dahi
    Dahi
  7. Scordo
    Scordo
  8. Shouval
    Shouval
  9. Hajj
    Hajj
  10. Imber
    Imber

Groups

  1. Adult Leukemia (9)
  2. Bone Marrow Transplant (9)
  3. Center for Hematologic Malignancies (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. Survivorship Research (9)
  7. Lymphoma (8)
  8. CTCR Scholars (7)
  9. MSK Grad Students (6)
  10. Master of Science in Clinical and Translational Cancer Research (6)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Jae Park"
  3. "Miguel-Angel Perales"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Adult Leukemia (9)
  2. Bone Marrow Transplant (9)
  3. Center for Hematologic Malignancies (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. Survivorship Research (9)

More Groups

People
  1. Jae Park (9)
  2. Miguel-Angel Perales (9)
  3. Craig Sauter (8)
  4. Maria Palomba (8)
  5. Gunjan Shah (7)
  6. Sergio Giralt (7)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2020 (2)
  4. 2019 (1)
  5. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Transplantation and Cellular Therapy (3)
  3. International Journal of Radiation Oncology, Biology, Physics (2)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save